An evaluation of the initial distribution volume of glucose to assess plasma volume during a fluid challenge. 2005

Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
Surgical Intensive Care Unit, University Hospital, 1011 Lausanne, Switzerland.

Circulation blood volume can be estimated with the initial distribution volume of glucose (IDVG) method. In a prospective, observational study, we evaluated the effect of a fluid challenge on IDVG in individual patients. In 13 patients after cardiac surgery, IDVG was determined before and after the infusion of 7 mL/kg hydroxyethyl starch over 30 min. Eleven patients not requiring a fluid challenge served as control. IDVG was computed with a one-compartment exponential model, using plasma glucose concentrations at baseline and 3, 4, 5, 6, and 7 min after 5 g of glucose IV bolus. IDVG was repeated 3 times in the control group. IDVG did not change after a fluid challenge (85 +/- 14 versus 93 +/- 14 mL/kg, P = 0.08), and the power of the comparison was 0.25 for a P value of 0.05. The regression coefficient of the exponential fit of glucose versus time was 0.96 +/- 0.03 before, and 0.95 +/- 0.04 after starch infusion (not significant). In the control group, IDVG was 90 +/- 18 mL/kg, and the average individual coefficient of variation was 0.15 +/- 0.08. IDVG seems inadequate to assess individual response to fluid therapy. This limitation may be related to the weak reproducibility of IDVG. CONCLUSIONS The initial distribution volume of glucose (IDVG) is supposed to reflect effective circulating blood volume. We assessed the sensitivity of this method to a fluid challenge in patients receiving a fluid challenge, and the reproducibility in otherwise stable patients. IDVG was not sensitive to a fluid challenge, and reproducibility was poor. Thus, clinical usefulness of IDVG seems limited.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010952 Plasma Substitutes Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. Blood Expanders,Plasma Volume Expanders,Expanders, Blood,Expanders, Plasma Volume,Substitutes, Plasma,Volume Expanders, Plasma
D010953 Plasma Volume Volume of PLASMA in the circulation. It is usually measured by INDICATOR DILUTION TECHNIQUES. Blood Plasma Volume,Blood Plasma Volumes,Plasma Volumes,Volume, Blood Plasma,Volume, Plasma,Volumes, Blood Plasma,Volumes, Plasma
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005440 Fluid Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS. Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006895 Hydroxyethyl Starch Derivatives Starches that have been chemically modified so that a percentage of OH groups are substituted with 2-hydroxyethyl ether groups. Hetastarch,Elohes,HAES-steril,Hemohes,Hespan,Hydroxyethyl Starch (130 KD-0.4 Substitution),Hydroxyethyl Starch 130-0.4,Hydroxyethylated Starches,Pentafraction,Pentaspan,Pentastarch,Plasmasteril,Starches, 2-Hydroxyethyl,2-Hydroxyethyl Starches,Derivatives, Hydroxyethyl Starch,Hydroxyethyl Starch 130 0.4,Starch Derivatives, Hydroxyethyl,Starches, 2 Hydroxyethyl,Starches, Hydroxyethylated
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
October 1995, Infusionstherapie und Transfusionsmedizin,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
August 2001, Critical care medicine,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
February 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
January 2023, Journal of clinical medicine,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
April 1999, British journal of clinical pharmacology,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
January 2008, Journal of anesthesia,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
June 2006, Anesthesia and analgesia,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
March 1996, Journal of anesthesia,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
January 2008, Neurourology and urodynamics,
Laurence van Tulder, and Burkhardt Michaeli, and René Chioléro, and Mette M Berger, and Jean-Pierre Revelly
September 2005, Chest,
Copied contents to your clipboard!